Office-based blue laser therapy for dyspnea in patients with type 3 Reinke’s edema
Purpose To investigate the effectiveness of in-office blue laser therapy on dyspnea in patients with type 3 Reinke’s edema. Methods The medical records and video-recordings of patients with Reinke’s edema type 3 who had undergone office-based blue laser therapy between March 2022 and January 2023 we...
Gespeichert in:
| Veröffentlicht in: | European archives of oto-rhino-laryngology 2023-07, Vol.280 (7), p.3323-3328 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3328 |
|---|---|
| container_issue | 7 |
| container_start_page | 3323 |
| container_title | European archives of oto-rhino-laryngology |
| container_volume | 280 |
| creator | Hamdan, Abdul-Latif Abou Raji Feghali, Patrick Hosri, Jad Abi Zeid Daou, Christophe Ghanem, Anthony |
| description | Purpose
To investigate the effectiveness of in-office blue laser therapy on dyspnea in patients with type 3 Reinke’s edema.
Methods
The medical records and video-recordings of patients with Reinke’s edema type 3 who had undergone office-based blue laser therapy between March 2022 and January 2023 were reviewed. The primary outcome measures assessed before and after surgery were dyspnea severity, risk of obstructive sleep apnea (OSA), and disease regression. The severity of dyspnea was measured using the Dyspnea Severity Index (DSI), the risk of OSA was assessed using the STOP-BANG questionnaire, and disease regression was assessed by reviewing the laryngeal examination before and after surgery. The Voice Handicap Index-10 (VHI-10) was used as a secondary outcome measure.
Result
A total of 10 patients were included. The mean age of the study population was 58.9 ± 4.2 years. The male-to-female ratio was 2:3. In total, 20 vocal fold lesions were treated among which 18 were reviewed. Eight lesions regressed completely and 10 partially. There was a statistically significant drop in the mean score of DSI after surgery (16.1 ± 10.2 pre-operatively vs 2.3 ± 2.3 post-operatively, p-value |
| doi_str_mv | 10.1007/s00405-023-07964-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2799827496</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2799827496</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-bc48e45d7e3462ad65a17013ebf118d1d3ed23aaf6b95ef8b5ca4998f7f6a5f03</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMozjj6Ai4kSzfVpEmbZiniDQYGZFyHtDlxOvZm0iLd-Rq-nk9itKNLV-fA-f4fzofQKSUXlBBx6QnhJIlIzCIiZMojvofmlLOwiDjdR3MimYg4F2KGjrzfEkISLtkhmjFBmMxkMkfrlbVlAVGuPRicVwPgKqwO9xtwuhuxbR02o-8a0LhscKf7Epre47ey3-B-7AAz_Ahl8wKf7x8eg4FaH6MDqysPJ7u5QE-3N-vr-2i5unu4vlpGBeOij_KCZ8ATI4DxNNYmTTQVhDLILaWZoYaBiZnWNs1lAjbLk0JzKTMrbKoTS9gCnU-9nWtfB_C9qktfQFXpBtrBq1gEOhZcpgGNJ7RwrfcOrOpcWWs3KkrUt0012VTBpvqxqXgIne36h7wG8xf51RcANgE-nJpncGrbDq4JP_9X-wVh7IEi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2799827496</pqid></control><display><type>article</type><title>Office-based blue laser therapy for dyspnea in patients with type 3 Reinke’s edema</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Hamdan, Abdul-Latif ; Abou Raji Feghali, Patrick ; Hosri, Jad ; Abi Zeid Daou, Christophe ; Ghanem, Anthony</creator><creatorcontrib>Hamdan, Abdul-Latif ; Abou Raji Feghali, Patrick ; Hosri, Jad ; Abi Zeid Daou, Christophe ; Ghanem, Anthony</creatorcontrib><description>Purpose
To investigate the effectiveness of in-office blue laser therapy on dyspnea in patients with type 3 Reinke’s edema.
Methods
The medical records and video-recordings of patients with Reinke’s edema type 3 who had undergone office-based blue laser therapy between March 2022 and January 2023 were reviewed. The primary outcome measures assessed before and after surgery were dyspnea severity, risk of obstructive sleep apnea (OSA), and disease regression. The severity of dyspnea was measured using the Dyspnea Severity Index (DSI), the risk of OSA was assessed using the STOP-BANG questionnaire, and disease regression was assessed by reviewing the laryngeal examination before and after surgery. The Voice Handicap Index-10 (VHI-10) was used as a secondary outcome measure.
Result
A total of 10 patients were included. The mean age of the study population was 58.9 ± 4.2 years. The male-to-female ratio was 2:3. In total, 20 vocal fold lesions were treated among which 18 were reviewed. Eight lesions regressed completely and 10 partially. There was a statistically significant drop in the mean score of DSI after surgery (16.1 ± 10.2 pre-operatively vs 2.3 ± 2.3 post-operatively, p-value < 0.001). The mean STOP-BANG score decreased from 4.8 ± 1.47 to 3.1 ± 1.28 (p-value = 0.001). There was also a significant improvement in VHI-10 score (22.7 ± 7.0 vs 4.4 ± 5.6, p-value < 0.001).
Conclusion
Office-based blue laser therapy offers a safe and effective treatment for shortness of breath in patients with type 3 Reinke’s edema.</description><identifier>ISSN: 0937-4477</identifier><identifier>EISSN: 1434-4726</identifier><identifier>DOI: 10.1007/s00405-023-07964-4</identifier><identifier>PMID: 37039895</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Dyspnea - etiology ; Edema - etiology ; Female ; Head and Neck Surgery ; Humans ; Laryngeal Edema - diagnosis ; Laryngology ; Laser Therapy ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Neurosurgery ; Otorhinolaryngology ; Vocal Cords - pathology</subject><ispartof>European archives of oto-rhino-laryngology, 2023-07, Vol.280 (7), p.3323-3328</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c347t-bc48e45d7e3462ad65a17013ebf118d1d3ed23aaf6b95ef8b5ca4998f7f6a5f03</citedby><cites>FETCH-LOGICAL-c347t-bc48e45d7e3462ad65a17013ebf118d1d3ed23aaf6b95ef8b5ca4998f7f6a5f03</cites><orcidid>0000-0003-1493-3568</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00405-023-07964-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00405-023-07964-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37039895$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hamdan, Abdul-Latif</creatorcontrib><creatorcontrib>Abou Raji Feghali, Patrick</creatorcontrib><creatorcontrib>Hosri, Jad</creatorcontrib><creatorcontrib>Abi Zeid Daou, Christophe</creatorcontrib><creatorcontrib>Ghanem, Anthony</creatorcontrib><title>Office-based blue laser therapy for dyspnea in patients with type 3 Reinke’s edema</title><title>European archives of oto-rhino-laryngology</title><addtitle>Eur Arch Otorhinolaryngol</addtitle><addtitle>Eur Arch Otorhinolaryngol</addtitle><description>Purpose
To investigate the effectiveness of in-office blue laser therapy on dyspnea in patients with type 3 Reinke’s edema.
Methods
The medical records and video-recordings of patients with Reinke’s edema type 3 who had undergone office-based blue laser therapy between March 2022 and January 2023 were reviewed. The primary outcome measures assessed before and after surgery were dyspnea severity, risk of obstructive sleep apnea (OSA), and disease regression. The severity of dyspnea was measured using the Dyspnea Severity Index (DSI), the risk of OSA was assessed using the STOP-BANG questionnaire, and disease regression was assessed by reviewing the laryngeal examination before and after surgery. The Voice Handicap Index-10 (VHI-10) was used as a secondary outcome measure.
Result
A total of 10 patients were included. The mean age of the study population was 58.9 ± 4.2 years. The male-to-female ratio was 2:3. In total, 20 vocal fold lesions were treated among which 18 were reviewed. Eight lesions regressed completely and 10 partially. There was a statistically significant drop in the mean score of DSI after surgery (16.1 ± 10.2 pre-operatively vs 2.3 ± 2.3 post-operatively, p-value < 0.001). The mean STOP-BANG score decreased from 4.8 ± 1.47 to 3.1 ± 1.28 (p-value = 0.001). There was also a significant improvement in VHI-10 score (22.7 ± 7.0 vs 4.4 ± 5.6, p-value < 0.001).
Conclusion
Office-based blue laser therapy offers a safe and effective treatment for shortness of breath in patients with type 3 Reinke’s edema.</description><subject>Dyspnea - etiology</subject><subject>Edema - etiology</subject><subject>Female</subject><subject>Head and Neck Surgery</subject><subject>Humans</subject><subject>Laryngeal Edema - diagnosis</subject><subject>Laryngology</subject><subject>Laser Therapy</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Neurosurgery</subject><subject>Otorhinolaryngology</subject><subject>Vocal Cords - pathology</subject><issn>0937-4477</issn><issn>1434-4726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKxDAUhoMozjj6Ai4kSzfVpEmbZiniDQYGZFyHtDlxOvZm0iLd-Rq-nk9itKNLV-fA-f4fzofQKSUXlBBx6QnhJIlIzCIiZMojvofmlLOwiDjdR3MimYg4F2KGjrzfEkISLtkhmjFBmMxkMkfrlbVlAVGuPRicVwPgKqwO9xtwuhuxbR02o-8a0LhscKf7Epre47ey3-B-7AAz_Ahl8wKf7x8eg4FaH6MDqysPJ7u5QE-3N-vr-2i5unu4vlpGBeOij_KCZ8ATI4DxNNYmTTQVhDLILaWZoYaBiZnWNs1lAjbLk0JzKTMrbKoTS9gCnU-9nWtfB_C9qktfQFXpBtrBq1gEOhZcpgGNJ7RwrfcOrOpcWWs3KkrUt0012VTBpvqxqXgIne36h7wG8xf51RcANgE-nJpncGrbDq4JP_9X-wVh7IEi</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Hamdan, Abdul-Latif</creator><creator>Abou Raji Feghali, Patrick</creator><creator>Hosri, Jad</creator><creator>Abi Zeid Daou, Christophe</creator><creator>Ghanem, Anthony</creator><general>Springer Berlin Heidelberg</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1493-3568</orcidid></search><sort><creationdate>20230701</creationdate><title>Office-based blue laser therapy for dyspnea in patients with type 3 Reinke’s edema</title><author>Hamdan, Abdul-Latif ; Abou Raji Feghali, Patrick ; Hosri, Jad ; Abi Zeid Daou, Christophe ; Ghanem, Anthony</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-bc48e45d7e3462ad65a17013ebf118d1d3ed23aaf6b95ef8b5ca4998f7f6a5f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Dyspnea - etiology</topic><topic>Edema - etiology</topic><topic>Female</topic><topic>Head and Neck Surgery</topic><topic>Humans</topic><topic>Laryngeal Edema - diagnosis</topic><topic>Laryngology</topic><topic>Laser Therapy</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Neurosurgery</topic><topic>Otorhinolaryngology</topic><topic>Vocal Cords - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hamdan, Abdul-Latif</creatorcontrib><creatorcontrib>Abou Raji Feghali, Patrick</creatorcontrib><creatorcontrib>Hosri, Jad</creatorcontrib><creatorcontrib>Abi Zeid Daou, Christophe</creatorcontrib><creatorcontrib>Ghanem, Anthony</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European archives of oto-rhino-laryngology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hamdan, Abdul-Latif</au><au>Abou Raji Feghali, Patrick</au><au>Hosri, Jad</au><au>Abi Zeid Daou, Christophe</au><au>Ghanem, Anthony</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Office-based blue laser therapy for dyspnea in patients with type 3 Reinke’s edema</atitle><jtitle>European archives of oto-rhino-laryngology</jtitle><stitle>Eur Arch Otorhinolaryngol</stitle><addtitle>Eur Arch Otorhinolaryngol</addtitle><date>2023-07-01</date><risdate>2023</risdate><volume>280</volume><issue>7</issue><spage>3323</spage><epage>3328</epage><pages>3323-3328</pages><issn>0937-4477</issn><eissn>1434-4726</eissn><abstract>Purpose
To investigate the effectiveness of in-office blue laser therapy on dyspnea in patients with type 3 Reinke’s edema.
Methods
The medical records and video-recordings of patients with Reinke’s edema type 3 who had undergone office-based blue laser therapy between March 2022 and January 2023 were reviewed. The primary outcome measures assessed before and after surgery were dyspnea severity, risk of obstructive sleep apnea (OSA), and disease regression. The severity of dyspnea was measured using the Dyspnea Severity Index (DSI), the risk of OSA was assessed using the STOP-BANG questionnaire, and disease regression was assessed by reviewing the laryngeal examination before and after surgery. The Voice Handicap Index-10 (VHI-10) was used as a secondary outcome measure.
Result
A total of 10 patients were included. The mean age of the study population was 58.9 ± 4.2 years. The male-to-female ratio was 2:3. In total, 20 vocal fold lesions were treated among which 18 were reviewed. Eight lesions regressed completely and 10 partially. There was a statistically significant drop in the mean score of DSI after surgery (16.1 ± 10.2 pre-operatively vs 2.3 ± 2.3 post-operatively, p-value < 0.001). The mean STOP-BANG score decreased from 4.8 ± 1.47 to 3.1 ± 1.28 (p-value = 0.001). There was also a significant improvement in VHI-10 score (22.7 ± 7.0 vs 4.4 ± 5.6, p-value < 0.001).
Conclusion
Office-based blue laser therapy offers a safe and effective treatment for shortness of breath in patients with type 3 Reinke’s edema.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>37039895</pmid><doi>10.1007/s00405-023-07964-4</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-1493-3568</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0937-4477 |
| ispartof | European archives of oto-rhino-laryngology, 2023-07, Vol.280 (7), p.3323-3328 |
| issn | 0937-4477 1434-4726 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2799827496 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Dyspnea - etiology Edema - etiology Female Head and Neck Surgery Humans Laryngeal Edema - diagnosis Laryngology Laser Therapy Male Medicine Medicine & Public Health Middle Aged Neurosurgery Otorhinolaryngology Vocal Cords - pathology |
| title | Office-based blue laser therapy for dyspnea in patients with type 3 Reinke’s edema |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T11%3A59%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Office-based%20blue%20laser%20therapy%20for%20dyspnea%20in%20patients%20with%20type%203%20Reinke%E2%80%99s%20edema&rft.jtitle=European%20archives%20of%20oto-rhino-laryngology&rft.au=Hamdan,%20Abdul-Latif&rft.date=2023-07-01&rft.volume=280&rft.issue=7&rft.spage=3323&rft.epage=3328&rft.pages=3323-3328&rft.issn=0937-4477&rft.eissn=1434-4726&rft_id=info:doi/10.1007/s00405-023-07964-4&rft_dat=%3Cproquest_cross%3E2799827496%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2799827496&rft_id=info:pmid/37039895&rfr_iscdi=true |